These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

538 related articles for article (PubMed ID: 19201294)

  • 1. HPV-16 infection predicts treatment outcome in oropharyngeal squamous cell carcinoma.
    Nichols AC; Faquin WC; Westra WH; Mroz EA; Begum S; Clark JR; Rocco JW
    Otolaryngol Head Neck Surg; 2009 Feb; 140(2):228-34. PubMed ID: 19201294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bcl2 and human papilloma virus 16 as predictors of outcome following concurrent chemoradiation for advanced oropharyngeal cancer.
    Nichols AC; Finkelstein DM; Faquin WC; Westra WH; Mroz EA; Kneuertz P; Begum S; Michaud WA; Busse PM; Clark JR; Rocco JW
    Clin Cancer Res; 2010 Apr; 16(7):2138-46. PubMed ID: 20233885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors and survival unique to surgically treated p16+ oropharyngeal cancer.
    Haughey BH; Sinha P
    Laryngoscope; 2012 Sep; 122 Suppl 2():S13-33. PubMed ID: 22926949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma.
    Licitra L; Perrone F; Bossi P; Suardi S; Mariani L; Artusi R; Oggionni M; Rossini C; Cantù G; Squadrelli M; Quattrone P; Locati LD; Bergamini C; Olmi P; Pierotti MA; Pilotti S
    J Clin Oncol; 2006 Dec; 24(36):5630-6. PubMed ID: 17179101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-risk human papillomavirus E6/E7 mRNA detection by a novel in situ hybridization assay strongly correlates with p16 expression and patient outcomes in oropharyngeal squamous cell carcinoma.
    Ukpo OC; Flanagan JJ; Ma XJ; Luo Y; Thorstad WL; Lewis JS
    Am J Surg Pathol; 2011 Sep; 35(9):1343-50. PubMed ID: 21836494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p16 not a prognostic marker for hypopharyngeal squamous cell carcinoma.
    Wilson DD; Rahimi AS; Saylor DK; Stelow EB; Jameson MJ; Shonka DC; Reibel JF; Levine PA; Read PW
    Arch Otolaryngol Head Neck Surg; 2012 Jun; 138(6):556-61. PubMed ID: 22710507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oropharyngeal squamous cell carcinoma treated with radiotherapy or radiochemotherapy: prognostic role of TP53 and HPV status.
    Fallai C; Perrone F; Licitra L; Pilotti S; Locati L; Bossi P; Orlandi E; Palazzi M; Olmi P
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1053-9. PubMed ID: 19577857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular classification identifies a subset of human papillomavirus--associated oropharyngeal cancers with favorable prognosis.
    Weinberger PM; Yu Z; Haffty BG; Kowalski D; Harigopal M; Brandsma J; Sasaki C; Joe J; Camp RL; Rimm DL; Psyrri A
    J Clin Oncol; 2006 Feb; 24(5):736-47. PubMed ID: 16401683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of the "violated neck" in the era of chemoradiation.
    Loyo M; Johnson JT; Westra WH; Chiosea SI; Gourin CG
    Laryngoscope; 2011 Nov; 121(11):2349-58. PubMed ID: 21993776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck.
    Lassen P; Eriksen JG; Hamilton-Dutoit S; Tramm T; Alsner J; Overgaard J
    J Clin Oncol; 2009 Apr; 27(12):1992-8. PubMed ID: 19289615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papillomavirus in metastatic lymph nodes from unknown primary head and neck squamous cell carcinoma.
    Compton AM; Moore-Medlin T; Herman-Ferdinandez L; Clark C; Caldito GC; Wang XI; Thomas J; Abreo FW; Nathan CO
    Otolaryngol Head Neck Surg; 2011 Jul; 145(1):51-7. PubMed ID: 21493313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining molecular phenotypes of human papillomavirus-associated oropharyngeal squamous cell carcinoma: validation of three-class hypothesis.
    Weinberger PM; Yu Z; Kountourakis P; Sasaki C; Haffty BG; Kowalski D; Merkley MA; Rimm DL; Camp RL; Psyrri A
    Otolaryngol Head Neck Surg; 2009 Sep; 141(3):382-9. PubMed ID: 19716018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biologic importance and prognostic significance of selected clinicopathological parameters in patients with oral and oropharyngeal squamous cell carcinoma, with emphasis on smoking, protein p16(INK4a) expression, and HPV status.
    Laco J; Nekvindova J; Novakova V; Celakovsky P; Dolezalova H; Tucek L; Vosmikova H; Vosmik M; Neskudlova T; Cermakova E; Hacova M; Sobande FA; Ryska A
    Neoplasma; 2012; 59(4):398-408. PubMed ID: 22489695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P16INK4a expression, human papillomavirus, and survival in head and neck cancer.
    Smith EM; Wang D; Kim Y; Rubenstein LM; Lee JH; Haugen TH; Turek LP
    Oral Oncol; 2008 Feb; 44(2):133-42. PubMed ID: 17360226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic signatures of HPV-related and unrelated oropharyngeal carcinoma and their prognostic implications.
    Klussmann JP; Mooren JJ; Lehnen M; Claessen SM; Stenner M; Huebbers CU; Weissenborn SJ; Wedemeyer I; Preuss SF; Straetmans JM; Manni JJ; Hopman AH; Speel EJ
    Clin Cancer Res; 2009 Mar; 15(5):1779-86. PubMed ID: 19223504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is the improved prognosis of p16 positive oropharyngeal squamous cell carcinoma dependent of the treatment modality?
    Fischer CA; Zlobec I; Green E; Probst S; Storck C; Lugli A; Tornillo L; Wolfensberger M; Terracciano LM
    Int J Cancer; 2010 Mar; 126(5):1256-62. PubMed ID: 19697324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-risk HPV DNA status and p16 (INK4a) expression as prognostic markers in patients with squamous cell cancer of oral cavity and oropharynx.
    Śnietura M; Jaworska M; Pigłowski W; Goraj-Zając A; Woźniak G; Lange D
    Pol J Pathol; 2010; 61(3):133-9. PubMed ID: 21225495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of HPV status on treatment of squamous cell cancer of the oropharynx: what we know and what we need to know.
    Tribius S; Ihloff AS; Rieckmann T; Petersen C; Hoffmann M
    Cancer Lett; 2011 May; 304(2):71-9. PubMed ID: 21376458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of patients after treatment for a squamous cell carcinoma of the oropharynx.
    Röösli C; Tschudi DC; Studer G; Braun J; Stoeckli SJ
    Laryngoscope; 2009 Mar; 119(3):534-40. PubMed ID: 19235752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer stem cell enrichment marker CD98: a prognostic factor for survival in patients with human papillomavirus-positive oropharyngeal cancer.
    Rietbergen MM; Martens-de Kemp SR; Bloemena E; Witte BI; Brink A; Baatenburg de Jong RJ; Leemans CR; Braakhuis BJ; Brakenhoff RH
    Eur J Cancer; 2014 Mar; 50(4):765-73. PubMed ID: 24315751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.